Pure Global AI
NCT06128473Completed

Clinical Evaluation of the Safety and Efficacy of Yung Sheng 38% Color Contact Lens

Yung Sheng Optical Co., Ltd.ClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Myopia
Drug/Device/Intervention
Soft Contact Lens
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Yung Sheng Optical Co., Ltd.
Timeline & enrollment
Phase
N/A
Start date
Jun 18, 2013
End date
Jul 03, 2014
Enrollment
71 participants
Primary outcome

The effectiveness of corrected visual acuity

Summary

This was a single group, open-label clinical study to assess the safety and efficacy of Yung
 Sheng 38% color contact lens for vision correction.

ICD-10 classifications
MyopiaDegenerative myopiaAmblyopia ex anopsiaOcular myiasisMyiasis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06128473
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06128473 through Pure Global AI's free database. This phase not specified trial is sponsored by Yung Sheng Optical Co., Ltd. and is currently Completed. The study focuses on Myopia. Target enrollment is 71 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.